• 主页
  • 查找结果
  • Vitamin D deficiency and its correction in children with sickle cell anaemia.

Vitamin D deficiency and its correction in children with sickle cell anaemia.

Annals of hematology (2014-07-02)
Clare Wykes, Anita Arasaretnam, Sandra O'Driscoll, Laura Farnham, Caje Moniz, David C Rees
摘要

Vitamin D deficiency is common in sickle cell anaemia (SCA, HbSS), although its significance and optimal means of correction are unknown. We conducted an audit to assess the clinical significance of 25-hydroxy vitamin D (25-OHD) deficiency in children with SCA and to evaluate two methods of vitamin D supplementation. We audited 25-OHD levels in 81 children with SCA and looked for statistical associations with biochemical, haematological and clinical parameters. In a separate group of regularly transfused children with SCA, we compared changes in 25-OHD blood concentrations following treatment with either high-dose intramuscular ergocalciferol (n = 15) or 4 days of high-dose oral cholecalciferol (n = 64). Ninety-one percent of children with SCA had 25-OHD levels <20 μg/L. The 25-OHD levels were negatively correlated with increasing age (P < 0.001) but showed no significant relationship to laboratory measurements, transcranial Doppler velocities or hospital attendance. Both intramuscular ergocalciferol and oral cholecalciferol supplementations resulted in increases of 25-OHD blood concentration to normal levels. The mean dose of ergocalciferol was greater than that of cholecalciferol (7,729 versus 5,234 international units (IU)/kg, P < 0.001), but the increment in 25-OHD levels was significantly greater in the oral cholecalciferol group (6.44 versus 2.82 (ng/L)/(IU/kg), P < 0.001). Both approaches resulted in vitamin D sufficiency for about 120 days. Increased 25-OHD concentration was significantly associated with increased serum calcium concentration. Vitamin D deficiency is very common in SCA and can be effectively corrected with high-dose intramuscular ergocalciferol or 4 days of high-dose oral cholecalciferol. Prospective, randomised studies are needed to assess the clinical value of vitamin D supplementation.

材料
货号
品牌
产品描述

Sigma-Aldrich
胆钙化醇, ≥98% (HPLC)
Supelco
胆钙化醇, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
碱性磷酸酶 来源于牛肠粘膜, BioUltra, buffered aqueous glycerol solution, ≥6,000 DEA units/mg protein
Sigma-Aldrich
碱性磷酸酶 来源于牛肠粘膜, lyophilized powder, ≥10 DEA units/mg solid
Supelco
胆钙化固醇(维生素 D3), analytical standard
Sigma-Aldrich
碱性磷酸酶 来源于牛肠粘膜, buffered aqueous solution, ≥2,000 DEA units/mg protein
Supelco
25-羟基维生素D3标准液 CRM 溶液, 100 μg/mL in ethanol, ampule of 1 mL, certified reference material, Cerilliant®
Sigma-Aldrich
磷酸酶(碱性) 来源于小牛肠, buffered aqueous glycerol solution
Supelco
维生素D3标准液 CRM 溶液, 1 mg/mL in ethanol, ampule of 1 mL, certified reference material, Cerilliant®
Sigma-Aldrich
碱性磷酸酶 来源于大肠杆菌, lyophilized powder, 30-60 units/mg protein (in glycine buffer)
Sigma-Aldrich
25-羟基胆钙化醇, ≥98% (HPLC)
USP
胆钙化醇, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
胆钙化醇, meets USP testing specifications
胆钙化醇, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
碱性磷酸酶 来源于牛肠粘膜, buffered aqueous glycerol solution, ≥4,000 DEA units/mg protein
Sigma-Aldrich
胆钙化醇, analytical standard
Sigma-Aldrich
碱性磷酸酶 来源于牛肠粘膜, ≥2,000 DEA units/mg protein
胆钙化醇, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
碱性磷酸酶 来源于牛肠粘膜, buffered aqueous glycerol solution, ≥5,500 DEA units/mg protein
Sigma-Aldrich
碱性磷酸酶 来源于大肠杆菌, ammonium sulfate suspension, 30-90 units/mg protein (modified Warburg-Christian, in glycine buffer)
Sigma-Aldrich
磷酸酶(碱性) 牛, recombinant, expressed in Pichia pastoris, ≥4000 units/mg protein
Sigma-Aldrich
3--25-羟基维生素 D3, 98% (CP)
Sigma-Aldrich
碱性磷酸酶 来源于大肠杆菌, buffered aqueous glycerol solution, 20-50 units/mg protein (in glycine buffer)
Sigma-Aldrich
碱性磷酸酶 来源于猪肾脏, lyophilized powder, ≥100 DEA units/mg protein
Supelco
25-羟基维生素D3标准液 CRM 溶液, 5 μg/mL in ethanol, ampule of 1 mL, certified reference material, Cerilliant®
Sigma-Aldrich
磷酸酶,碱性虾, ≥1,000 DEA units/mL, buffered aqueous glycerol solution, recombinant, expressed in proprietary host
Sigma-Aldrich
磷酸酶(碱性) 来源于牛肾, lyophilized powder, ≥5 units/mg protein (Activity determined in diethanolamine buffer, pH 9.8)

社交媒体

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon

Merck

科研、开发、生产。

作为生命科学行业的全球领先供应商,我们致力于为科研、生物技术开发和生产,以及制药药物疗法开发和生产提供各类解决方案和服务。

© 2021年版权归德国达姆施塔特默克集团(Merck KGaA)及/或其附属公司所有。版权所有。

未经许可,严禁复制本网站上的任何资料。